ABOUT THIS EVENT

Portage Biotech (Nasdaq: PRTG), a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, visits the Nasdaq MarketSite in Times Square to celebrate the Company’s uplisting to Nasdaq earlier this year and clinical and corporate advancements made in recent months. 

In honor of the occasion, Portage’s Chief Executive Officer, Ian Walters, rings the Opening Bell.